Equilis® Prequenza Te, Suspension for injection for horses
Equilis Prequenza Te is designed to stimulate active immunity against influenza and tetanus.
Presentation
Clear opalescent suspension
Active ingredients
Per dose of 1 ml:
Equine influenza virus strains:
A/equine-2/South Africa/4/03 - 50 AU1
A/equine-2/Newmarket/2/93 - 50 AU1
Tetanus toxoid - 40 Lf2
1 Antigenic units
2 Flocculation equivalents; corresponds with ≥ 30 IU/ml guinea pig serum in the Ph.Eur. potency test
Target species
Horses
Indications for use
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality.
Influenza
|
Onset of immunity |
2 weeks after primary vaccination course |
|---|---|
|
Duration of immunity |
5 months after the primary vaccination course |
|
|
1 year after the first revaccination |
Tetanus
|
Onset of immunity |
2 weeks after the primary vaccination course |
|---|---|
|
Duration of immunity |
17 months after the primary vaccination course |
|
|
2 years after the first revaccination |
Withdrawal periods
Horses - Zero days
Packaging
Cardboard box with 10 glass vials of 1 ml (1 dose)
Cardboard box with 5 pre-filled syringes of 1 ml (1 dose) with needles
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: September 2024